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The liver is critical for maintaining systemic energy
balance during starvation. To understand the role of
hepatic fatty acid b-oxidation on this process, we
generated mice with a liver-specific knockout of
carnitine palmitoyltransferase 2 (Cpt2L/), an obli-
gate step in mitochondrial long-chain fatty acid
b-oxidation. Fasting induced hepatic steatosis and
serum dyslipidemia with an absence of circulating
ketones, while blood glucose remained normal. Sys-
temic energy homeostasis was largely maintained in
fasting Cpt2L/ mice by adaptations in hepatic and
systemic oxidative gene expression mediated in
part by Ppara target genes including procatabolic
hepatokines Fgf21, Gdf15, and Igfbp1. Feeding a
ketogenic diet to Cpt2L/ mice resulted in severe
hepatomegaly, liver damage, and death with a com-
plete absence of adipose triglyceride stores. These
data show that hepatic fatty acid oxidation is not
required for survival during acute food deprivation
but essential for constraining adipocyte lipolysis
and regulating systemic catabolism when glucose
is limiting.
INTRODUCTION
Starvation initiates a series of metabolic adaptations to enable
continuous production and delivery of nutrients to critical or-
gans, tissues, and cells (Cahill, 2006). This response is coordi-
nated in large part by the liver that responds by liberating
glucose to the circulation initially from glycogen stores fol-
lowed by de novo glucose production (i.e., gluconeogenesis).
Additionally, ketones are produced and provide an alternative
energy source to glucose for highly oxidative tissues such as
the brain (Owen et al., 1967). Fatty acid oxidation is critical for
these processes as it provides the carbon substrate for keto-
genesis (acetyl-CoA) and mitochondrial bioenergetics (ATP,
NADH) to facilitate gluconeogenesis. Therefore, humans with
disparate inborn errors in mitochondrial fatty acid oxidation
exhibit life-threatening hypoketotic-hypoglycemia following a
fast (IJlst et al., 1998). Systemically, the liver produces mostC
This is an open access article under the CC BY-Nof the circulating ketones due to its high capacity for b-oxida-
tion and lack of the CoA transferase (Oxct1) in hepatocytes
that is required to utilize ketones (Cotter et al., 2011).
Also, the liver is thought to dominate fasting gluconeogenesis
with minor contributions from the kidney and gut. Interest-
ingly, mice with a hepatocyte-specific loss of glucose-6-phos-
phatase, the obligate terminal enzyme in cellular glucose
liberation, do not exhibit reduced blood glucose following
fasting or starvation, although ketone production is acceler-
ated (Mutel et al., 2011). Therefore, extra-hepatic gluconeo-
genic tissues can fully compensate for a loss of hepatic
production.
Mitochondrial long-chain fatty acid b-oxidation is governed
by the regulated translocation of activated fatty acids (acyl-
CoAs) from the cytoplasm to the mitochondrial matrix medi-
ated by successive carnitine acyltransferases (McGarry and
Brown, 1997). Carnitine Palmitoyltransfersase 1 (Cpt1) isoen-
zymes mediate acyl transfer from long-chain acyl-CoAs to
carnitine on the outer mitochondrial membrane, generating
acylcarnitines that can traverse through the Carnitine-acylcar-
nitine translocase within the inner mitochondrial membrane.
Within the mitochondrial matrix, Cpt2 transfers the acyl group
from the acylcarnitine back onto CoA, enabling b-oxidation.
Human inborn errors in Cpt2 result in increasing severity of
metabolic disease (OMIM numbers, 255110 adult onset,
600649 infantile, and 600650 infantile lethal) (Isackson et al.,
2008; Longo et al., 2006). The complete loss of Cpt1a or
Cpt1b is embryonic lethal in mice, and the loss of Acadl or
Acadm results in increased neonatal death (Ji et al., 2008;
Kurtz et al., 1998; Nyman et al., 2005). The loss of other mito-
chondrial components of b-oxidation results in multisystemic
defects as well as cell-specific compensatory mechanisms
(Spiekerkoetter and Wood, 2010; Tolwani et al., 2005; Zhang
et al., 2007, 2010).
To understand the contribution of hepatic fatty acid oxida-
tion during fasting and starvation, we generated mice with
a liver-specific knockout of Carnitine Palmitoyltransferase 2
(Cpt2L/), an obligate enzyme in mitochondrial long-chain fatty
acid b-oxidation encoded by a single gene. To our great surprise,
Cpt2L/mice not only survived the perinatal period, but also did
not exhibit alterations in blood glucose following a 24-hr fast
although ketones were absent. Fasting resulted in serum dyslipi-
demia, hepatic steatosis, and alterations in hepatic and systemic
oxidative gene expression. Although Cpt2L/mice were able toell Reports 16, 201–212, June 28, 2016 ª 2016 The Author(s). 201
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Characterization of Mice with a
Liver-Specific KO of CPT2
(A) Western blot for CPT2 in liver of Cpt2lox/lox and
Cpt2L/ mice.
(B) mRNA for Cpt2 across different tissues (n = 6).
(C) Oxidation of 1-14C-oleic acid and 1-14C-
Lignoceric acid to 14CO2 in liver slices of Cpt2
lox/lox
and Cpt2L/ mice (n = 5).
(D) Body weights of Cpt2lox/lox and Cpt2L/ male
and female mice fed a normal chow diet (males,
n = 14–23; females, n = 8–12).
Data are expressed as mean ± SEM. *p < 0.05;
**p < 0.01; ***p < 0.001.adapt to survive a 24-hr fast, feeding them a ketogenic diet re-
sulted in hepatomegaly and death after only 6 days with a com-
plete absence of adipose triglyceride stores. These data show
that hepatic fatty acid oxidation is not required for survival during
acute food deprivation but is essential for constraining adipocyte
lipolysis and regulating systemic catabolism when glucose is
limiting.RESULTS
Generation of Mice with a Liver-Specific Deficiency in
Fatty Acid b-Oxidation
Previously, we generated amousemodel with a conditional loss-
of-function allele forCpt2, an obligate step inmitochondrial long-
chain fatty acid b-oxidation (Lee et al., 2015, 2016). To produce
mice with a loss of Cpt2 specifically in hepatocytes, we bred
Cpt2lox/lox mice to liver-specific albumin-Cre transgenic mice
(Postic et al., 1999). The resulting liver-specific Cpt2 knockout
(KO) mice (Cpt2L/) showed a loss of Cpt2 protein in the liver
(Figure 1A) and decreased mRNA levels of Cpt2 specifically in
the liver (Figure 1B). As expected, oleate oxidation was signifi-
cantly suppressed in the liver of Cpt2L/ mice to a similar de-
gree as incubation with 100 mM of the CPT inhibitor, etomoxir
(Nomura et al., 2016). There was no change in the oxidation of
the very-long-chain fatty acid, lignoceric acid, which is preferen-
tially oxidized in peroxisomes (Figure 1C). Although males had a
small suppression of body weight after weaning, females did not
show suppressed body weight, and all mice exhibited normal
body weight by 6 weeks of age (Figure 1D). These data show
that the loss of hepatic mitochondrial long-chain fatty acid
b-oxidation is not required for survival to adulthood. This is sur-
prising given the requirement for fatty acid b-oxidation during the
perinatal period (Boles et al., 1998; Rinaldo et al., 2002; Tolwani
et al., 2005).202 Cell Reports 16, 201–212, June 28, 2016Fasting Results in Hypoketotic
Dyslipidemia in Cpt2L/ Mice
To determine the requirements for hepat-
ic fatty acid oxidation upon food depriva-
tion, we fasted Cpt2lox/lox and Cpt2L/
mice for 24 hr at 9 weeks of age. As ex-
pected, there was a significant decrease
in serum b-hydroxybutyrate (bHB) in
Cpt2L/mice even in the fed state. Con-
trol Cpt2lox/lox mice dramatically increased serum bHB upon a
24-hr fast as expected, while Cpt2L/ mice did not exhibit
appreciable serum bHB consistent with the a loss of hepatic fatty
acid oxidation (Figure 2A). Additionally, fasting induced serum
dyslipidemia with increased NEFA and cholesterol in Cpt2L/
mice (Figure 2A). Cpt2L/ mice did not become hypoglycemic
following the 24-hr fast nor was insulin different between geno-
types (Figure 2A). Because the liver plays an integral role in fatty
acid metabolism in the body, we determined whole-body bioen-
ergetics in Cpt2L/ mice. Interestingly, there was no change in
energy expenditure between Cpt2lox/lox and Cpt2L/ mice in
fed, fasted, or refed states (Figure 2B). Although Cpt2L/ mice
exhibit clear metabolic deficiencies, in the context of whole-an-
imal energy homeostasis, Cpt2lox/lox and Cpt2L/ mice were
able to maintain equivalent energy expenditure and respiratory
exchange ratio even during fasting (Figure 2B). Food intake,
body composition, and ambulatory activity were not different be-
tween male or female Cpt2lox/lox and Cpt2L/ mice (Figures 2C
and S1A–S1D). Examination of tissue weights in Cpt2lox/lox and
Cpt2L/mice showed that fasting resulted in a greater suppres-
sion in gonadal white adipose tissue (gWAT) in Cpt2L/ mice,
while there was a concomitant increase in liver weight (Fig-
ure 2D). Consistent with the wet weight data, Cpt2L/ livers
were enlarged and lipid laden following a 24-hr fast (Figure 2E).
Liver triglyceride levels were unchanged in the fed state but
were significantly increased in Cpt2L/mice compared to con-
trol Cpt2lox/lox mice upon fasting (Figure 2F). There were not
signs of liver damage by serum ALT activity (Figure 2G), altered
corticosterone levels (Figure S1E), or significant markers of ER
stress (Figure S1F) following a 24-hr fast. However, Cpt2L/
livers did show significant lipid peroxidation following fasting
(Figure 2H). These data show that mice with a loss of hepatic
fatty acid b-oxidation can adapt to maintain systemic energy ho-
meostasis during a fast but not without adverse consequences
to the liver and adipose tissue stores.
Figure 2. Liver and Systemic Deficits in Fed and 24-hr-Fasted Cpt2L/ Mice
(A) Serum metabolites in Cpt2lox/lox and Cpt2L/ mice (n = 6).
(B) Energy expenditure and respiratory exchange ratio of Cpt2lox/lox and Cpt2L/ mice under fed, fast, and refed conditions (males, n = 5–7).
(C) Total fat and lean mass of Cpt2lox/lox and Cpt2L/ male mice (n = 5–7).
(D) Wet weights of fed or 24-hr-fasted iWAT, gWAT, and liver for Cpt2lox/lox and Cpt2L/ mice (n = 6–10).
(E) Gross and histological morphology of livers from 24-hr-fasted Cpt2lox/lox and Cpt2L/ mice. Scale bar, 100 mM.
(F) Triglyceride levels from liver homogenates of fed and 24-hr-fasted Cpt2lox/lox and Cpt2L/ mice (n = 5).
(G) Liver damage measured by serum ALT activity of fed and 24-hr-fasted Cpt2lox/lox and Cpt2L/ mice (n = 5).
(H) TBARS assay measuring lipid peroxidation from liver of fed and 24-hr-fasted Cpt2lox/lox and Cpt2L/ mice (n = 5).
Data are expressed as mean ± SEM. *p < 0.05; **p < 0.01; ***p < 0.001.Fasting Increases Oxidative and Suppresses Lipogenic
Programing in Livers of Cpt2L/ Mice
Given the robust physiological and cellular adaptations in
Cpt2L/mice, we determined hepatic gene expression of select
fatty acid metabolic genes in fed and fasted Cpt2lox/lox and
Cpt2L/ mice. First, we determined the expression of fatty
acid oxidation genes. In the fed state, there were increases in
Acsl1, Acot1, and Acot2 mRNA in the livers of Cpt2L/ mice
(Figure 3A). Acot1 and Acot2 were also increased at the protein
level in the livers of fed Cpt2L/ mice (Figure 3B). Following a
24-hr fast, the increases in Acot1 and Acot2 in the livers of fedCpt2L/ mice were greatly exacerbated as well as increases
in the fatty acid oxidative genes, Acox1, Acadl, and Hadha (Fig-
ure 3A). These changes were largely mirrored at the protein level
by western blotting (Figure 3B). Many of the fatty acid biosyn-
thetic genes were suppressed following a 24-hr fast in livers of
Cpt2L/ mice compared to Cpt2lox/lox mice (Figures 3B and
S2A). Gluconeogenic gene expression was not altered in
Cpt2L/ mice with the exception of Pck2 whose contribution
to gluconeogenesis is not well defined (Figure S3A). These
data show a robust upregulation of fatty acid catabolic genes
and suppression of fatty acid anabolic genes in the livers ofCell Reports 16, 201–212, June 28, 2016 203
Figure 3. Loss of Hepatic Fatty Acid Oxidation Induces Expression of Fatty Acid Oxidative Genes
(A) Gene expression of fatty acid oxidation genes in liver of fed and 24-hr-fasted Cpt2lox/lox and Cpt2L/ mice (n = 6).
(B) Western blots of proteins in fatty acid metabolism. Composite of eight blots. All blots were normalized to Hsc70 (Figure S2).
(C) Liver mRNA (n = 6) of Fgf21, Gdf15, and Igfbp1 in fed and 24-hr-fasted Cpt2lox/lox and Cpt2L/ mice.
(D) Serum concentrations (n = 8) of Fgf21, Gdf15, and Igfbp1 in fed and 24-hr-fasted Cpt2lox/lox and Cpt2L/ mice.
Data are expressed as mean ± SEM. *p < 0.05; **p < 0.01; ***p < 0.001.Cpt2L/ mice that were exacerbated by fasting. This suggests
that the fatty acid oxidation-deficient livers were attempting to
compensate for the lack of fatty acid oxidation in the face of a
large lipid burden.
Fasting Induces Ppara Target Genes and Procatabolic
Hepatokines Fgf21, Gdf15, and Igfbp1 in Cpt2L/ Mice
Due to the robust transcriptional response in Cpt2L/ mice, we
decided to probe further into the transcriptional alterations in
the livers of Cpt2L/ mice. Therefore, we fasted Cpt2lox/lox and
Cpt2L/ mice for 24 hr for genome-wide gene expression
profiling on liver mRNA via DNAmicroarrays (Table 1). Microarray
analysis revealed a dramatic transcriptional dysregulation in the
livers of Cpt2L/ mice upon fasting. In order to validate the mi-
croarray results in a larger cohort of mice, we analyzed a subset
of genes identified in the microarray analysis by quantitative
real-time PCR in both fed and fasted Cpt2lox/lox and Cpt2L/
mice (Table 1). Consistent with the robust transcriptional and pro-
tein induction of Acot1 and Acot2, other type I ACOTs, canonical
Ppara target genes, were also identified in the microarray. Other
canonical Ppara target genes were also dramatically upregulated
such as Pdk4 (100-fold), Ehhadh (50-fold), Cd36, (10-fold),
and Fabp3 (160-fold) (Table 1). These data suggest that exoge-
nous fatty acid derived Ppara ligands build up in the face of
increased lipid delivery to the liver and are greatly potentiated in
the absence of mitochondrial fatty acid oxidation.204 Cell Reports 16, 201–212, June 28, 2016We were surprised that, although Cpt2L/ mice had clear
metabolic deficiencies, they were able to maintain systemic en-
ergy homeostasis even following a 24-hr fast. Therefore, we
were interested in determining how the Cpt2L/ liver might be
communicating these deficits with other tissues. Of interest
was one of the most highly upregulated genes in the livers of
Cpt2L/ mice (50-fold), the secreted hepatokine Fgf21 (Table
1; Figure 3C). Fgf21 is also a canonical Ppara target gene (Bad-
man et al., 2007; Inagaki et al., 2007). Consistent with the tran-
scriptional increase in Fgf21, serum Fgf21 was increased
(11.5-fold) in fasted Cpt2L/ mice compared with Cpt2lox/lox
littermate controls (Figures 3D). Additionally, Gdf15 and Igfbp1
mRNA were increased in fasted Cpt2L/ liver, and these were
also increased to a similar degree in Cpt2L/ serum (Figures
3C and 3D). These secreted proteins have all been shown to in-
crease systemic catabolism (Badman et al., 2007; Hsiao et al.,
2000; Inagaki et al., 2007; Johnen et al., 2007; Wheatcroft and
Kearney, 2009). These data suggest that the loss of hepatic fatty
acid oxidation is mitigated in part by increasing systemic proca-
tabolic hepatokines.
Fasting Induces Systemic Catabolic Gene Expression in
Cpt2L/ Mice
Somemetabolic processes that occur largely in the liver, such as
gluconeogenesis, can be supplanted in part by the kidney.
Therefore, we postulated that the kidney could be a major site
Table 1. Fasting and Diet-Induced Gene Expression in Cpt2L/ Liver
Gene
Fasted Fed Fasted Ketogenic Diet
Array KO/WT Lox/Lox Cpt2L/ Lox/Lox Cpt2L/ Lox/Lox Cpt2L/
Pdk4 30.5 1.0 ± 0.17 3.9 ± 0.39 1.2 ± 0.30 99.0 ± 16.22*** 1.0 ± 0.34 178.9 ± 41.42**
Elovl7 13.3 1.0 ± 0.17 2.1 ± 0.33 0.9 ± 0.24 174.9 ± 31.58*** 1.0 ± 0.46 58.7 ± 9.38***
Gpnmb 10.2 1.0 ± 0.26 2.2 ± 0.27 2.1 ± 0.51 301.7 ± 67.18*** 1.0 ± 0.35 134.9 ± 12.60***
Cpt1b 8.9 1.0 ± 0.10 4.4 ± 1.25 6.1 ± 2.42 84.5 ± 14.39*** 1.0 ± 0.23 9.9 ± 2.95*
Phospho1 7.6 1.0 ± 0.20 3.5 ± 0.22 1.8 ± 0.50 30.2 ± 7.71*** 1.0 ± 0.26 15.3 ± 3.18***
Fgf21 6.0 1.0 ± 0.15 5.4 ± 1.00 4.9 ± 2.12 54.6 ± 7.02*** 1.0 ± 0.26 13.9 ± 3.18**
Fabp3 5.8 1.0 ± 0.18 1.4 ± 0.24 2.4 ± 0.31 161.1 ± 21.31*** 1.0 ± 0.19 32.0 ± 3.71***
Atf3 5.4 1.0 ± 0.16 2.1 ± 0.43 0.9 ± 0.10 28.4 ± 4.18*** 1.0 ± 0.40 15.8 ± 2.58***
Cd68 5.0 1.0 ± 0.11 1.2 ± 0.27 0.8 ± 0.18 8.0 ± 1.09*** 1.0 ± 0.19 2.1 ± 0.15**
Igfbp1 4.4 1.0 ± 0.16 1.4 ± 0.25 0.7 ± 0.18 4.8 ± 1.08*** 1.0 ± 0.33 42.6 ± 13.62*
Acot2 4.4 1.0 ± 0.23 2.6 ± 0.52 5.8 ± 0.96 65.2 ± 11.33*** 1.0 ± 0.30 45.7 ± 13.80***
Plin4 4.2 1.0 ± 0.17 1.0 ± 0.25 1.0 ± 0.23 7.6 ± 1.04*** 1.0 ± 0.12 6.5 ± 1.07***
Jun 3.1 1.0 ± 0.17 1.8 ± 0.40 1.3 ± 0.42 5.8 ± 1.42*** 1.0 ± 0.22 4.4 ± 0.46***
Cd36 3.0 1.0 ± 0.15 1.7 ± 0.25 1.5 ± 0.28 9.9 ± 2.51*** 1.0 ± 0.26 7.5 ± 0.94***
Gdf15 3.0 1.0 ± 0.24 3.1 ± 0.49 1.0 ± 0.24 14.9 ± 2.81*** 1.0 ± 0.33 10.1 ± 1.47***
Acot1 3.0 1.0 ± 0.10 2.1 ± 0.23 4.5 ± 1.05 18.7 ± 2.47*** 1.0 ± 0.12 7.2 ± 1.41***
Agpat9 2.9 1.0 ± 0.15 4.0 ± 0.84 2.7 ± 0.49 10.1 ± 1.80*** 1.0 ± 0.21 3.2 ± 0.52 **
Pex11a 2.9 1.0 ± 0.08 1.8 ± 0.30 1.4 ± 0.35 4.5 ± 0.73*** 1.0 ± 0.07 2.2 ± 0.24***
Ehhadh 2.5 1.0 ± 0.21 1.4 ± 0.27 8.7 ± 1.54 49.4 ± 6.72*** 1.0 ± 0.16 10.1 ± 1.95***
Acot6 2.5 1.0 ± 0.22 2.3 ± 0.44 2.2 ± 0.52 6.9 ± 1.59*** 1.0 ± 0.20 1.8 ± 0.43
Myc 2.4 1.0 ± 0.17 1.2 ± 0.12 3.8 ± 0.95 10.8 ± 2.23*** 1.0 ± 0.28 5.4 ± 1.24 **
Gpd2 2.2 1.0 ± 0.16 1.3 ± 0.29 0.7 ± 0.12 1.9 ± 0.38** 1.0 ± 0.20 2.7 ± 0.59 **
Mtor 2.2 1.0 ± 0.17 1.6 ± 0.28 1.3 ± 0.14 3.2 ± 0.51*** 1.0 ± 0.07 2.0 ± 0.43 *
Plin5 2.2 1.0 ± 0.15 1.1 ± 0.28 1.6 ± 0.32 5.6 ± 0.55*** 1.0 ± 0.19 4.4 ± 1.14 **
Plin3 2.2 1.0 ± 0.13 1.3 ± 0.19 1.2 ± 0.18 3.5 ± 0.46*** 1.0 ± 0.15 2.8 ± 0.30***
Microarray on liver of 24-hr-fasted Cpt2lox/lox and Cpt2L/ mice (n = 3). Validation by quantitative real-time PCR in liver of fed and 24-hr-fasted
Cpt2lox/lox and Cpt2L/ mice (n = 6). Quantitative real-time PCR in liver of 6-day ketogenic-diet-fed Cpt2lox/lox and Cpt2L/ mice (n = 6). Data are
expressed as mean ± SEM. WT, wild-type. *p < 0.05; **p < 0.01; ***p < 0.001.of systemic compensation of energy homeostasis. First, we as-
sessed the regulation of oxidative gene expression in the kidneys
of fed and 24-hr-fasted Cpt2lox/lox and Cpt2L/ mice. Fasting
initiated a robust increase in the expression of genes involved
in fatty acid oxidation in the kidneys of Cpt2L/ mice similar to
the elevation in liver (Figure 4A). A subset of these genes was
also validated at the protein level (Figure 4B). Similar to the liver,
gluconeogenic gene expression was not altered in Cpt2L/
mice with the exception of Pck2 (Figure S3B). Upon dissection,
the kidneys of 24-hr-fasted Cpt2L/ mice were visibly lipid
laden (Figure 4C). Although the wet weight of the kidneys of
Cpt2lox/lox and Cpt2L/ mice were similar, the kidneys of
Cpt2L/mice exhibited an2-fold increase in total triglycerides
consistent with increased uptake of fatty acids (Figures 4D and
4E). These data support the kidney as a major site of compensa-
tion in fasted Cpt2L/ mice.
Fgf21 has been shown to regulate ketogenic and oxidative
genes in the liver in an autocrine manner. Fgf21 has also been
postulated to affect adipocyte energy balance in an endocrine
manner (Fisher and Maratos-Flier, 2016). Since fasting induces
a robust increase in circulating Fgf21 in Cpt2L/ mice, we
examined some of the putative endocrine effects of Fgf21 treat-ment in a more physiological model. Interscapular BAT (iBAT) of
Cpt2L/ mice did not exhibit transcriptional increases in ther-
mogenic genes (Figure 4F), but fasting elicited increases in
Ucp1, Cidea, and Fgf21 in inguinal WAT (iWAT) of Cpt2L/
mice (Figure 4G) consistent with fasting-induced Fgf21 target
gene expression in this tissue (Fisher et al., 2012). Adipose-
derived Adiponectin has also been shown to be a pharmacologic
target of Fgf21 (Holland et al., 2013; Lin et al., 2013). However,
we did not observe an increase in adiponectin mRNA in gonadal
WAT (gWAT) nor did we observe changes in serum Adiponectin
between fed or fasting Cpt2lox/lox and Cpt2L/mice (Figure 4H).
Due to the robust contribution of skeletal muscle and heart to
whole-body fatty acid oxidation, we examined fatty acid oxida-
tive gene expression in these tissues. Although the transcrip-
tional response was not as robust as the kidney in these tissues,
fasting-induced a significant increase in Acot1 and Acot2 in
Cpt2L/ gastrocnemius muscle (Figure 4I) and induced a
significant increase in Acot1 in the Cpt2L/ heart (Figure S3C).
Interestingly, along with liver and iWAT, skeletal muscle of
Cpt2L/ mice also exhibited a significant fasting-induced in-
crease in Fgf21 expression (Figure 4J). Together, these data
suggest that loss of hepatic fatty acid oxidationmay bemitigatedCell Reports 16, 201–212, June 28, 2016 205
Figure 4. Loss of Hepatic Fatty Acid Oxidation Results in Compensation from the Kidney, Muscle, and Adipose Tissue
(A) Gene expression of fatty acid oxidation genes in the kidney of fed and 24-hr-fasted Cpt2lox/lox and Cpt2L/ mice (n = 6).
(B) Western blots of proteins in fatty acid metabolism. Composite of five blots. All blots were normalized to Hsc70 (Figure S3).
(C) Gross kidney morphology in 24-hr-fasted Cpt2lox/lox and Cpt2L/ mice.
(D) Kidney wet weight of fed and 24-hr-fasted Cpt2lox/lox and Cpt2L/ mice (n = 6–10).
(E) Kidney TAG content of fed and 24-hr-fasted Cpt2lox/lox and Cpt2L/ mice (n = 5).
(F) iBAT gene expression of fed and 24-hr-fasted Cpt2lox/lox and Cpt2L/ mice (n = 6).
(G) iWAT gene expression of fed and 24-hr-fasted Cpt2lox/lox and Cpt2L/ mice (n = 6).
(legend continued on next page)
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in part by the induction of procatabolic hepatokines such as
Fgf21 via both cell autonomous and non-cell autonomous
mechanisms.
A Ketogenic Diet Depletes Adipose Triglyceride Stores
and Is Lethal to Cpt2L/ Mice
Given the putative requirements for hepatic fatty acid oxidation,
we were surprised that Cpt2L/mice could survive a 24-hr fast.
To determine howCpt2L/mice would tolerate a long-term car-
bohydrate-limited diet, we placed 9-week-old Cpt2lox/lox and
Cpt2L/ mice on a low-carbohydrate ketogenic diet. After
6 days on the ketogenic diet, several Cpt2L/ mice died and
the remaining Cpt2L/ mice exhibited a dramatic weight loss
(Figure 5A). Cpt2L/ mice exhibited hepatomegaly (Figure 5B)
and significant liver damage as measured by serum ALT activity
(Figure 5C). These physiologic indicators were accompanied by
severe kyphosis and lethargy, suggesting a neurologic involve-
ment. Additionally, Cpt2L/ mice became hypoglycemic and
hypoketotic with corresponding serum dyslipidemia (Figure 5D).
Incredibly, upon dissection, Cpt2L/ mice completely lacked
observable white adipose tissue following 6 days on a ketogenic
diet, consistent with the loss of body weight (Figure 5E). These
data suggest that from a physiological standpoint, Cpt2L/
mice could not differentiate starvation from a high-calorie, low-
carbohydrate diet.
Fasting and a ketogenic diet share many metabolic features.
Therefore, we assessed the gene expression signature of
Cpt2lox/lox and Cpt2L/ mice fed a ketogenic diet for 6 days.
Consistent with the microarray data from 24-hr fasting liver, the
livers from Cpt2L/mice exhibited a dramatic increase in Ppar-
a-target gene expression compared to control Cpt2lox/lox mice
(170-fold increase in Pdk4, >50-fold increase in Elovl7) (Table
1). Also, oxidative gene expression in the livers of Cpt2L/
mice was increased in ketogenic-diet-fed mice (Figure 5F). Glu-
coneogeneic gene expression, serum insulin, and oxidative gene
expression in the kidney, gastrocnemius muscle, and heart were
also consistent with the fasting data (Figure S4). Finally, we
measured the gene expression (Table 1) and serum concentra-
tions of the secreted hepatokines Fgf21, Gdf15, and Igfbp1 (Fig-
ure 5G). Even though the ketogenic diet elicited a strong induc-
tion of these heptokines in control Cpt2lox/lox mice, Cpt2L/
mice further exacerbated this increase in serum hepatokines.
These data show that the ketogenic diet elicits a similar yet
further exacerbated physiologic program in Cpt2L/ mice
compared to fasting.
To better determine the kinetics of the ketogenic-induced
weight loss and hypoglycemia in mice deficient in hepatic fatty
acid b-oxidation, we again placed Cpt2lox/lox and Cpt2L/
mice on a ketogenic diet and measured their body weights and
blood glucose daily over 4 days. Cpt2lox/lox and Cpt2L/ mice
had no significant differences in fed blood glucose (Figure 6A)
or body weight (Figure 6B) over these 4 days, although, by day
4, Cpt2L/ mice had accelerated body weight loss. This indi-(H) gWAT adiponectin mRNA (n = 6) and Adiponectin serum concentration (n = 8
(I) Gene expression of fatty acid oxidation genes in the gastrocnemius muscle of
(J) Gastrocnemius muscle mRNA of Fgf21 in fed and 24-hr-fasted Cpt2lox/lox and
Data are expressed as mean ± SEM. *p < 0.05; **p < 0.01; ***p < 0.001.cates that a lack of systemic gluconeogenesis was not the pri-
mary cause of lethality in Cpt2L/ mice.
To determine the systemic metabolic effects of a loss of
hepatic Cpt2, we measured blood and tissue acylcarnitines in
Cpt2lox/lox and Cpt2L/ mice before and over the 4-day keto-
genic diet challenge. As the liver is a major site of carnitine
biosynthesis, there were no changes in free carnitine in the liver;
however, there was a significant suppression in free carnitine in
the blood of Cpt2L/ mice, indicating a systemic deficiency
(Figure 6C). Total acylcarnitines and short-chain acylcarnitines
were significantly suppressed in both chow and ketogenic-
diet-fed blood of Cpt2L/mice (Figure 6D; Table S1). However,
the substrates specific for Cpt2, long-chain acylcarnitines,
showed a progressive increase in blood over time, indicating
increased hepatic excursion of long-chain acylcarnitines in
Cpt2L/ mice (Figure 6E; Table S1). Finally, we measured liver
acylcarnitines in chow fed and 4-day ketogenic diet fed mice.
Consistent with a block in fatty acid b-oxidation, Cpt2L/
mice exhibited a suppression in liver acetylcarnitine that was
exacerbated by the ketogenic diet (Figure 6F), and an increase
in long-chain acylcarnitines even in chow fed mice (Figure 6G;
Table S2). These data show that a loss of hepatic fatty acid
b-oxidation results in an accelerated depletion of adipose lipid
stores and increased peripheral catabolism following fasting or
a ketogenic diet that is ultimately unsustainable.
DISCUSSION
The importance of fatty acid b-oxidation is made evident by mul-
tiple inborn errors in this pathway that cause serious human dis-
ease (Brivet et al., 1999; Longo et al., 2006;Wanders et al., 1999).
For example, hypomorphicmutations in CPT2 result inmetabolic
disease of increasing severity. Themost severe form presents as
hypothermia, cardiomegaly, hepatomegaly, and hypoglycemia
in the first days of life from the important roles of fatty acid
b-oxidation in adipocytes, heart, and liver. Additionally, hypo-
morphic mutations in CPT1a result in hypoketotic-hypoglycemia
(IJlst et al., 1998) and a loss of CPT1a or CPT1b in mice is early
embryonic lethal (Ji et al., 2008; Nyman et al., 2005). Given that
the liver is critical for the adaptation to fasting and fatty acid
b-oxidation is central to this response, we asked what the re-
quirements of hepatic fatty acid b-oxidation are in vivo. Surpris-
ingly, we found that mice with a hepatocyte-specific deletion of
mitochondrial long-chain fatty acid b-oxidation survived not only
the perinatal period, but also survived a 24-hr fast with normal
blood glucose but a lack of ketone bodies. Perhaps not surpris-
ingly, survival during food deprivation has been so evolutionarily
important that multiple compensatory systems are in place for
such a critical adaptation.
While blood glucose is maintained within a tight range, ke-
tones can change dramatically from micromolar to millimolar
concentrations (Cahill, 2006). Our data suggest that the liver
produces almost all of the circulating ketones. The total loss of) of fed and 24-hr-fasted Cpt2lox/lox and Cpt2L/ mice.
fed and 24-hr-fasted Cpt2lox/lox and Cpt2L/ mice (n = 6).
Cpt2L/ mice (n = 6).
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Figure 5. A Ketogenic Diet Results in Hypoglycemia, a Depletion of Adipose Triglyceride, and Eventually Lethality in Cpt2L/ Mice
(A) Body weights of Cpt2lox/lox and Cpt2L/ mice fed a normal chow or ketogenic diet for 6 days (normal chow, n = 6–10; ketogenic diet, n = 5–6).
(B) Wet weight of liver from Cpt2lox/lox and Cpt2L/ mice fed a ketogenic diet for 6 days (n = 5–6).
(C) Liver damage measured by serum ALT activity of Cpt2lox/lox and Cpt2L/ mice fed a ketogenic diet (n = 5).
(D) Serum metabolites in Cpt2lox/lox and Cpt2L/ mice after a 6-day ketogenic diet (n = 5–6).
(E) Gross morphology of Cpt2lox/lox and Cpt2L/ mice fed a ketogenic diet.
(F) Gene expression of fatty acid oxidation genes in the liver of Cpt2lox/lox and Cpt2L/ mice fed a ketogenic diet (n = 6).
(G) Serum concentrations of Fgf21, Gdf15, and Igfbp1 of Cpt2lox/lox and Cpt2L/ mice fed a ketogenic diet (n = 6).
Data are expressed as mean ± SEM. *p < 0.05; **p < 0.01; ***p < 0.001.ketone utilization via KO of Oxct1 results in perinatal lethality in
mice (Cotter et al., 2011). Therefore, we speculate that local
ketone production (e.g., within the CNS) or a small amount of
fatty acid independent ketogenesis may enable the survival of
Cpt2L/mice during the perinatal period, a time of robust ketol-
ysis (Auestad et al., 1991; Guzma´n and Bla´zquez, 2004). Several
effects of bHB indirectly associated with its metabolic role have
been suggested (Newman and Verdin, 2014). bHB is an endog-
enous ligand for at least two Gi/o-coupled GPCRs, HCAR2 and
FFAR3, that suppress adipose lipolysis and sympathetic activity,
respectively (Kimura et al., 2011; Taggart et al., 2005). Given the208 Cell Reports 16, 201–212, June 28, 2016dramatic peripheral catabolism in ketogenic-diet-fed Cpt2L/
mice that have suppressed circulating bHB, these nonmetabolic
roles of ketones likely play a significant role in regulating sys-
temic physiology during food deprivation. The inability to affect
these two receptors would lead to enhanced fasting lipolysis
consistent with Cpt2L/ mice. Therefore, bHB is likely critical
for restraining lipolysis, particularly under conditions where insu-
lin is low.
Ppara has been postulated to be activated by fatty-acid-
derived ligands. Some ligands are thought to be derived from
de novo fatty acid synthesis (Chakravarthy et al., 2005, 2007,
Figure 6. Time Course of Body Weight, Blood Glucose, and Acylcarnitines in Cpt2L/ Mice Fed a Ketogenic Diet
(A) Blood glucose of Cpt2lox/lox and Cpt2L/ mice during a 4-day ketogenic diet (n = 5).
(B) Body weight of Cpt2lox/lox and Cpt2L/ mice during a 4-day ketogenic diet (n = 5).
(C) Liver and blood L-carnitine of Cpt2lox/lox and Cpt2L/ mice following a 4-day ketogenic diet (n = 5).
(D) Total blood acylcarnitines and acetylcarnitine of Cpt2lox/lox and Cpt2L/ mice following a 4-day ketogenic diet (n = 5).
(E) Daily blood long-chain (C18:0, C18:1) acylcarnitines of Cpt2lox/lox and Cpt2L/ mice during a 4-day ketogenic diet (n = 5).
(F) Total liver acylcarnitines and acetylcarnitine of Cpt2lox/lox and Cpt2L/ mice following a 4-day ketogenic diet (n = 4–5).
(G) Total liver long-chain (C16:0, C18:0, C18:1) acylcarnitines and acetylcarnitine of Cpt2lox/lox and Cpt2L/ mice following a 4-day ketogenic diet (n = 4–5).
Data are expressed as mean ± SEM. *p < 0.05; **p < 0.01; ***p < 0.001.2009); however, that seems to be an unlikely driver of fasting
gene expression in Cpt2L/ mice. Alternatively, triglyceride
hydrolysis has been shown to be critical for Ppara directed tran-
scription. The loss of Atgl, the rate-setting step in triglyceride hy-drolysis, results in a loss of Ppara transcription presumably from
the loss of an endogenous Ppara ligand produced upon hydroly-
sis (Ahmadian et al., 2011; Haemmerle et al., 2011; Mottillo et al.,
2012; Schoiswohl et al., 2015). It will be interesting to determineCell Reports 16, 201–212, June 28, 2016 209
whether lipids derived from lipid droplet triglyceride hydrolysis
are required for the increased Ppara-mediated transcription in
Cpt2L/ mice or, alternatively, whether exogenous lipid uptake
can directly activate Ppara target genes independent of lipid
droplets.
One robust transcriptional target of Ppara is the hepatokine
Fgf21 (Badman et al., 2007; Inagaki et al., 2007). Although it is ex-
pressed in several tissues, most of the circulating Fgf21 is
derived from hepatocytes (Markan et al., 2014). Fgf21 is induced
by fasting and ketogenic feeding in rodents and acts largely to
increase energy expenditure via an autocrine and endocrine
manner (Fisher and Maratos-Flier, 2016). Fgf21 is emerging as
a potential therapeutic for obesity and insulin resistance by
increasing glucose uptake in adipocytes and increasing energy
expenditure. The robust increase in circulating Fgf21 in
Cpt2L/ mice suggests that it provides some of the signal
required to increase systemic catabolism to maintain energy ho-
meostasis although Gdf15 and Igfbp1 likely also contribute.
Consistent with Cpt2L/ mice, humans with mitochondrial dis-
ease exhibit increased circulating FGF21 (Davis et al., 2013).
The loss of the anti-catabolic bHB and the gain of procatabolic
hepatokines such as Fgf21, Gdf15, and Igfbp1 likely all
contribute to the exaggerated lipolysis seen in Cpt2L/ mice
upon fasting or ketogenic feeding and mitigate hepatic energy
expenditure defects in mice without the capacity for long-chain
mitochondrial fatty acid b-oxidation.
It is clear that the liver plays an important role in regulating sys-
temic metabolism, and that hepatic fatty acid b-oxidation repre-
sents an important component, particularly when carbohydrate
intake is limiting. However, our data show that there is an incred-
ible systemic adaptation mediated by the liver to regulate extra-
hepatic metabolism to ensure survival. These data highlight the
need to better understand the tissue-specific contributions of
macronutrient metabolism to gain insight into the regulation of
integrative metabolic physiology.
EXPERIMENTAL PROCEDURES
Animals
To generate a liver-specific loss of function of Cpt2, we bred Cpt2lox/lox mice
(Lee et al., 2015) to albumin-Cre transgenic mice (Postic et al., 1999). Mice
were housed in ventilated racks with a 14-hr-light/10-hr-dark cycle and fed a
standard chow diet (Harlan Laboratories). All mice were euthanized at the
same time of day (3 p.m.). Fed mice were food deprived from 1 p.m. to
3 p.m. to ensure consistent feeding patterns. For fasting studies, mice were
deprived of food for 24 hr from 3 p.m. to 3 p.m. For the ketogenic diet studies,
mice were placed on a ketogenic diet at 9 weeks of age (Ellis et al., 2015).
Serum was collected for all mice to measure free glycerol and TAG (Sigma),
b-hydroxybutyrate (StanBio), total cholesterol, NEFA (Wako), and ALT (Sigma).
Fgf21, Gdf15, Igfbp1, Corticosterone, and Adiponectin (R&D Systems) and in-
sulin (Millipore) were measured by ELISA. Body fat and lean mass of 9-week-
old mice were measured via magnetic resonance imaging analysis (QNMR
EchoMRI100; Echo Medical Systems). Indirect calorimetery and metabolic
cage studies were normalized to total lean mass as described (Ellis et al.,
2013). All procedures were performed in accordance with the NIH’s Guide
for the Care and Use of Laboratory Animals and under the approval of the
Johns Hopkins Medical School Animal Care and Use Committee.
Metabolic Measurements
Blood levels of acylcarnitines were quantified from dried blood spots (DBSs)
with modifications (Chace et al., 1997; Sandlers et al., 2012). Punched one-210 Cell Reports 16, 201–212, June 28, 2016eighth-inch DBS samples were submerged in 100 ml of methanol solution con-
taining internal standards for acyl carnitines (NSK B, Cambridge Isotopes).
Samples were incubated at 4C for 20 min and dried under nitrogen and
then 60 ml 3N HCl in n-butanol was added. The samples were incubated for
15 min at 65C and then dried under LN2, and butylated acyl carnitines were
reconstituted in 100 ml of mobile phase acetonitrile/water/formic acid (H2
O:CH3CN:HCOOH; 80:19.9:0.1 v/v%). Samples were vortexed, transferred
to a centrifuge filter, spun, and transferred to an injection vial. Tissue acyl car-
nitines were isolated from freeze-clamped tissue and homogenized in a meth-
anol solution containing internal standards as above, sonicated for 10 min at
room temperature, and centrifuged for 4 min at 13,000 rpm at 4C. Following
centrifugation, the liquid phase was collected and evaporated to dryness un-
der LN2 and processed as above. Acyl carnitines were analyzed on an API
3200 (AB SCIEX) operated in positive ion mode employing precursor ion
scan for m/z 85, which is generated as a characteristic product ion of butyl
ester of acyl carnitine species. Quantitation of acyl carnitines was achieved
by Chemoview (AB SCIEX) application. All blood samples are reported as
nmol/ml; tissue samples as pmol/mg. Liver fatty acid oxidation, TAGmeasure-
ment, and liver peroxidation were done as previously described (Ellis et al.,
2013, 2015).
Real-Time qPCR
RNA was isolated from all tissues using the RNeasy Mini Kit (QIAGEN). Us-
ing the High Capacity cDNA Reverse Transcription Kit (Applied Bio-
systems), we reverse transcribed 1–2 mg of total RNA. The cDNA was
diluted to 2 ng/ml and amplified by primers in a 20-ml reaction using SsoAd-
vanced SYBR Green Supermix (Bio-Rad). The analysis was done using a
CFX Connect Real-Time System (Bio-Rad). We calculated mRNA using a
2^deltaCT relative to the average of the housekeeping genes cyclophilin
A, rpl22, and 18 s expression. ER stress was measured as described else-
where (Jiang et al., 2014). All primers and gene information were previously
reported (Lee et al., 2015).
Western Blot
Liver and kidney homogenates were prepared using 1 3 radio immunopre-
cipitation assay (RIPA) buffer with protease inhibitors. The protein concentra-
tion was measured using the Pierce BCA Protein Assay kit (Thermo Scienti-
fic). We used 30 mg of protein on an SDS-PAGE and then transferred it to
either a nitrocellulose (Protran BA 83, Whatman) or a polyvinylidene fluoride
(PVDF) membrane. We then blocked with 3% BSA-TBST (Tris-buffered sa-
line with Tween 20). The membranes were then probed with antibodies
Cpt2 (Pierce), Pgc1a (Abcam), Acsl1 (Cell Signaling Technology), Acot1
(Cell Signaling), Acot2 (Cell Signaling), Cpt1a (Abcam), Acadm (GeneTex),
Acsf3 (Pierce), Total Acc (Cell Signaling), Acly (Cell Signaling), Hadha (Gene-
tex), Aco2 (Cell Signaling), Fasn (BD Biosciences), and Hsc70 (Santa Cruz
Biotechnology). Hsc70 used the appropriate Cy3 fluorescent secondary an-
tibodies, and the other primary antibodies used the corresponding second-
ary antibodies conjugated to horseradish peroxidase. Images were collected
using an Alpha Innotech FluorChemQ and presented with minimal image
processing.
Statistical Analysis
Data were analyzed with the assistance of Prism. Significance was determined
using an unpaired two-tailed Student’s t test for single variable experiments
and two-way ANOVA with Bonferroni post hoc correction for multiple variable
experiments.
ACCESSION NUMBERS
The accession number for the mRNA expression data reported in this paper is
GEO: GSE76079.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures and two tables and can be
foundwith this article online at http://dx.doi.org/10.1016/j.celrep.2016.05.062.
AUTHOR CONTRIBUTIONS
J.L., J.C., S.S., and M.J.W. performed experiments and wrote the manuscript.ACKNOWLEDGMENTS
The authors would like to thank Susan Aja for assistance with the metabolic
cage studies. This work was supported in part by a pilot and feasibility award
from the Mid-Atlantic Nutrition Obesity Research Center P30DK072488,
American Diabetes Association grant #1-16-IBS-313 toM.J.W. and NIH grants
R01NS072241 toM.J.W. and K08NS069815 to S.S. J.L. was supported in part
by T32GM007445.
Received: February 3, 2016
Revised: April 14, 2016
Accepted: May 16, 2016
Published: June 16, 2016REFERENCES
Ahmadian, M., Abbott, M.J., Tang, T., Hudak, C.S., Kim, Y., Bruss, M., Heller-
stein, M.K., Lee, H.Y., Samuel, V.T., Shulman, G.I., et al. (2011). Desnutrin/
ATGL is regulated by AMPK and is required for a brown adipose phenotype.
Cell Metab. 13, 739–748.
Auestad, N., Korsak, R.A., Morrow, J.W., and Edmond, J. (1991). Fatty acid
oxidation and ketogenesis by astrocytes in primary culture. J. Neurochem.
56, 1376–1386.
Badman, M.K., Pissios, P., Kennedy, A.R., Koukos, G., Flier, J.S., and Mara-
tos-Flier, E. (2007). Hepatic fibroblast growth factor 21 is regulated by PPAR-
alpha and is a key mediator of hepatic lipid metabolism in ketotic states. Cell
Metab. 5, 426–437.
Boles, R.G., Buck, E.A., Blitzer, M.G., Platt, M.S., Cowan, T.M., Martin, S.K.,
Yoon, H., Madsen, J.A., Reyes-Mugica, M., and Rinaldo, P. (1998). Retrospec-
tive biochemical screening of fatty acid oxidation disorders in postmortem
livers of 418 cases of sudden death in the first year of life. J. Pediatr. 132,
924–933.
Brivet, M., Boutron, A., Slama, A., Costa, C., Thuillier, L., Demaugre, F., Rabier,
D., Saudubray, J.M., and Bonnefont, J.P. (1999). Defects in activation and
transport of fatty acids. J. Inherit. Metab. Dis. 22, 428–441.
Cahill, G.F., Jr. (2006). Fuel metabolism in starvation. Annu. Rev. Nutr. 26,
1–22.
Chace, D.H., Hillman, S.L., Van Hove, J.L., and Naylor, E.W. (1997). Rapid
diagnosis of MCAD deficiency: quantitative analysis of octanoylcarnitine and
other acylcarnitines in newborn blood spots by tandem mass spectrometry.
Clin. Chem. 43, 2106–2113.
Chakravarthy, M.V., Pan, Z., Zhu, Y., Tordjman, K., Schneider, J.G., Coleman,
T., Turk, J., and Semenkovich, C.F. (2005). ‘‘New’’ hepatic fat activates PPAR-
alpha to maintain glucose, lipid, and cholesterol homeostasis. Cell Metab. 1,
309–322.
Chakravarthy, M.V., Zhu, Y., Lo´pez, M., Yin, L., Wozniak, D.F., Coleman, T.,
Hu, Z., Wolfgang, M., Vidal-Puig, A., Lane, M.D., and Semenkovich, C.F.
(2007). Brain fatty acid synthase activates PPARalpha to maintain energy ho-
meostasis. J. Clin. Invest. 117, 2539–2552.
Chakravarthy, M.V., Lodhi, I.J., Yin, L., Malapaka, R.R., Xu, H.E., Turk, J., and
Semenkovich, C.F. (2009). Identification of a physiologically relevant endoge-
nous ligand for PPARalpha in liver. Cell 138, 476–488.
Cotter, D.G., d’Avignon, D.A., Wentz, A.E., Weber, M.L., and Crawford, P.A.
(2011). Obligate role for ketone body oxidation in neonatal metabolic homeo-
stasis. J. Biol. Chem. 286, 6902–6910.
Davis, R.L., Liang, C., Edema-Hildebrand, F., Riley, C., Needham,M., and Sue,
C.M. (2013). Fibroblast growth factor 21 is a sensitive biomarker of mitochon-
drial disease. Neurology 81, 1819–1826.Ellis, J.M., Wong, G.W., and Wolfgang, M.J. (2013). Acyl coenzyme A thio-
esterase 7 regulates neuronal fatty acid metabolism to prevent neurotoxicity.
Mol. Cell. Biol. 33, 1869–1882.
Ellis, J.M., Bowman, C.E., and Wolfgang, M.J. (2015). Metabolic and tissue-
specific regulation of acyl-CoA metabolism. PLoS ONE 10, e0116587.
Fisher, F.M., and Maratos-Flier, E. (2016). Understanding the Physiology of
FGF21. Annu. Rev. Physiol. 78, 223–241.
Fisher, F.M., Kleiner, S., Douris, N., Fox, E.C., Mepani, R.J., Verdeguer, F., Wu,
J., Kharitonenkov, A., Flier, J.S., Maratos-Flier, E., and Spiegelman, B.M.
(2012). FGF21 regulates PGC-1a and browning of white adipose tissues in
adaptive thermogenesis. Genes Dev. 26, 271–281.
Guzma´n, M., and Bla´zquez, C. (2004). Ketone body synthesis in the brain:
possible neuroprotective effects. Prostaglandins Leukot. Essent. Fatty Acids
70, 287–292.
Haemmerle, G., Moustafa, T., Woelkart, G., B€uttner, S., Schmidt, A., van de
Weijer, T., Hesselink, M., Jaeger, D., Kienesberger, P.C., Zierler, K., et al.
(2011). ATGL-mediated fat catabolism regulates cardiac mitochondrial func-
tion via PPAR-a and PGC-1. Nat. Med. 17, 1076–1085.
Holland, W.L., Adams, A.C., Brozinick, J.T., Bui, H.H., Miyauchi, Y., Kusminski,
C.M., Bauer, S.M.,Wade,M., Singhal, E., Cheng, C.C., et al. (2013). An FGF21-
adiponectin-ceramide axis controls energy expenditure and insulin action in
mice. Cell Metab. 17, 790–797.
Hsiao, E.C., Koniaris, L.G., Zimmers-Koniaris, T., Sebald, S.M., Huynh, T.V.,
and Lee, S.J. (2000). Characterization of growth-differentiation factor 15, a
transforming growth factor beta superfamily member induced following liver
injury. Mol. Cell. Biol. 20, 3742–3751.
Inagaki, T., Dutchak, P., Zhao, G., Ding, X., Gautron, L., Parameswara, V., Li,
Y., Goetz, R., Mohammadi, M., Esser, V., et al. (2007). Endocrine regulation of
the fasting response by PPARalpha-mediated induction of fibroblast growth
factor 21. Cell Metab. 5, 415–425.
Isackson, P.J., Bennett, M.J., Lichter-Konecki, U., Willis, M., Nyhan,W.L., Sut-
ton, V.R., Tein, I., and Vladutiu, G.D. (2008). CPT2 gene mutations resulting in
lethal neonatal or severe infantile carnitine palmitoyltransferase II deficiency.
Mol. Genet. Metab. 94, 422–427.
Ji, S., You, Y., Kerner, J., Hoppel, C.L., Schoeb, T.R., Chick, W.S., Hamm,
D.A., Sharer, J.D., and Wood, P.A. (2008). Homozygous carnitine palmitoyl-
transferase 1b (muscle isoform) deficiency is lethal in the mouse. Mol. Genet.
Metab. 93, 314–322.
Jiang, S., Yan, C., Fang, Q.C., Shao, M.L., Zhang, Y.L., Liu, Y., Deng, Y.P.,
Shan, B., Liu, J.Q., Li, H.T., et al. (2014). Fibroblast growth factor 21 is regu-
lated by the IRE1a-XBP1 branch of the unfolded protein response and coun-
teracts endoplasmic reticulum stress-induced hepatic steatosis. J. Biol.
Chem. 289, 29751–29765.
Johnen, H., Lin, S., Kuffner, T., Brown, D.A., Tsai, V.W., Bauskin, A.R., Wu, L.,
Pankhurst, G., Jiang, L., Junankar, S., et al. (2007). Tumor-induced anorexia
and weight loss are mediated by the TGF-beta superfamily cytokine MIC-1.
Nat. Med. 13, 1333–1340.
Kimura, I., Inoue, D., Maeda, T., Hara, T., Ichimura, A., Miyauchi, S., Kobaya-
shi, M., Hirasawa, A., and Tsujimoto, G. (2011). Short-chain fatty acids and ke-
tones directly regulate sympathetic nervous system via G protein-coupled re-
ceptor 41 (GPR41). Proc. Natl. Acad. Sci. USA 108, 8030–8035.
Kurtz, D.M., Rinaldo, P., Rhead, W.J., Tian, L., Millington, D.S., Vockley, J.,
Hamm, D.A., Brix, A.E., Lindsey, J.R., Pinkert, C.A., et al. (1998). Targeted
disruption of mouse long-chain acyl-CoA dehydrogenase gene reveals crucial
roles for fatty acid oxidation. Proc. Natl. Acad. Sci. USA 95, 15592–15597.
IJlst, L., Mandel, H., Oostheim, W., Ruiter, J.P., Gutman, A., andWanders, R.J.
(1998). Molecular basis of hepatic carnitine palmitoyltransferase I deficiency.
J. Clin. Invest. 102, 527–531.
Lee, J., Ellis, J.M., and Wolfgang, M.J. (2015). Adipose fatty acid oxidation is
required for thermogenesis and potentiates oxidative stress-induced inflam-
mation. Cell Rep. 10, 266–279.Cell Reports 16, 201–212, June 28, 2016 211
Lee, J., Choi, J., Aja, S., Scafidi, S., and Wolfgang, M.J. (2016). Loss of Adi-
pose Fatty Acid Oxidation Does Not Potentiate Obesity at Thermoneutrality.
Cell Rep. 14, 1308–1316.
Lin, Z., Tian, H., Lam, K.S., Lin, S., Hoo, R.C., Konishi, M., Itoh, N., Wang, Y.,
Bornstein, S.R., Xu, A., and Li, X. (2013). Adiponectin mediates the metabolic
effects of FGF21 on glucose homeostasis and insulin sensitivity in mice. Cell
Metab. 17, 779–789.
Longo, N., Amat di San Filippo, C., and Pasquali, M. (2006). Disorders of carni-
tine transport and the carnitine cycle. Am. J. Med. Genet. C. Semin. Med.
Genet. 142C, 77–85.
Markan, K.R., Naber, M.C., Ameka, M.K., Anderegg, M.D., Mangelsdorf, D.J.,
Kliewer, S.A., Mohammadi, M., and Potthoff, M.J. (2014). Circulating FGF21 is
liver derived and enhances glucose uptake during refeeding and overfeeding.
Diabetes 63, 4057–4063.
McGarry, J.D., and Brown, N.F. (1997). The mitochondrial carnitine palmitoyl-
transferase system. From concept tomolecular analysis. Eur. J. Biochem. 244,
1–14.
Mottillo, E.P., Bloch, A.E., Leff, T., and Granneman, J.G. (2012). Lipolytic prod-
ucts activate peroxisome proliferator-activated receptor (PPAR) a and d in
brown adipocytes to match fatty acid oxidation with supply. J. Biol. Chem.
287, 25038–25048.
Mutel, E., Gautier-Stein, A., Abdul-Wahed, A., Amigo´-Correig, M., Zitoun, C.,
Stefanutti, A., Houberdon, I., Tourette, J.A., Mithieux, G., and Rajas, F.
(2011). Control of blood glucose in the absence of hepatic glucose production
during prolonged fasting in mice: induction of renal and intestinal gluconeo-
genesis by glucagon. Diabetes 60, 3121–3131.
Newman, J.C., and Verdin, E. (2014). Ketone bodies as signaling metabolites.
Trends Endocrinol. Metab. 25, 42–52.
Nomura, M., Liu, J., Rovira, I.I., Gonzalez-Hurtado, E., Lee, J., Wolfgang, M.J.,
and Finkel, T. (2016). Fatty acid oxidation in macrophage polarization. Nat. Im-
munol. 17, 216–217.
Nyman, L.R., Cox, K.B., Hoppel, C.L., Kerner, J., Barnoski, B.L., Hamm, D.A.,
Tian, L., Schoeb, T.R., and Wood, P.A. (2005). Homozygous carnitine palmi-
toyltransferase 1a (liver isoform) deficiency is lethal in the mouse. Mol. Genet.
Metab. 86, 179–187.
Owen, O.E., Morgan, A.P., Kemp, H.G., Sullivan, J.M., Herrera, M.G., and
Cahill, G.F., Jr. (1967). Brain metabolism during fasting. J. Clin. Invest. 46,
1589–1595.
Postic, C., Shiota, M., Niswender, K.D., Jetton, T.L., Chen, Y., Moates, J.M.,
Shelton, K.D., Lindner, J., Cherrington, A.D., and Magnuson, M.A. (1999).212 Cell Reports 16, 201–212, June 28, 2016Dual roles for glucokinase in glucose homeostasis as determined by liver
and pancreatic beta cell-specific gene knock-outs using Cre recombinase.
J. Biol. Chem. 274, 305–315.
Rinaldo, P., Matern, D., and Bennett, M.J. (2002). Fatty acid oxidation disor-
ders. Annu. Rev. Physiol. 64, 477–502.
Sandlers, Y., Moser, A.B., Hubbard, W.C., Kratz, L.E., Jones, R.O., and
Raymond, G.V. (2012). Combined extraction of acyl carnitines and 26:0 lyso-
phosphatidylcholine from dried blood spots: prospective newborn screening
for X-linked adrenoleukodystrophy. Mol. Genet. Metab. 105, 416–420.
Schoiswohl, G., Stefanovic-Racic, M., Menke, M.N., Wills, R.C., Surlow, B.A.,
Basantani, M.K., Sitnick, M.T., Cai, L., Yazbeck, C.F., Stolz, D.B., et al. (2015).
Impact of reduced ATGL-mediated adipocyte lipolysis on obesity-associated
insulin resistance and inflammation in male mice. Endocrinology 156, 3610–
3624.
Spiekerkoetter, U., and Wood, P.A. (2010). Mitochondrial fatty acid oxidation
disorders: pathophysiological studies in mouse models. J. Inherit. Metab.
Dis. 33, 539–546.
Taggart, A.K., Kero, J., Gan, X., Cai, T.Q., Cheng, K., Ippolito, M., Ren, N., Ka-
plan, R., Wu, K., Wu, T.J., et al. (2005). (D)-beta-Hydroxybutyrate inhibits
adipocyte lipolysis via the nicotinic acid receptor PUMA-G. J. Biol. Chem.
280, 26649–26652.
Tolwani, R.J., Hamm, D.A., Tian, L., Sharer, J.D., Vockley, J., Rinaldo, P., Ma-
tern, D., Schoeb, T.R., and Wood, P.A. (2005). Medium-chain acyl-CoA dehy-
drogenase deficiency in gene-targeted mice. PLoS Genet. 1, e23.
Wanders, R.J., Vreken, P., den Boer, M.E., Wijburg, F.A., van Gennip, A.H.,
and IJlst, L. (1999). Disorders of mitochondrial fatty acyl-CoA beta-oxidation.
J. Inherit. Metab. Dis. 22, 442–487.
Wheatcroft, S.B., and Kearney, M.T. (2009). IGF-dependent and IGF-indepen-
dent actions of IGF-binding protein-1 and -2: implications for metabolic ho-
meostasis. Trends Endocrinol. Metab. 20, 153–162.
Zhang, D., Liu, Z.X., Choi, C.S., Tian, L., Kibbey, R., Dong, J., Cline, G.W.,
Wood, P.A., and Shulman, G.I. (2007). Mitochondrial dysfunction due to
long-chain Acyl-CoA dehydrogenase deficiency causes hepatic steatosis
and hepatic insulin resistance. Proc. Natl. Acad. Sci. USA 104, 17075–17080.
Zhang, D., Christianson, J., Liu, Z.X., Tian, L., Choi, C.S., Neschen, S., Dong,
J., Wood, P.A., and Shulman, G.I. (2010). Resistance to high-fat diet-induced
obesity and insulin resistance in mice with very long-chain acyl-CoA dehydro-
genase deficiency. Cell Metab. 11, 402–411.
